Last updated: February 19, 2026
What is NDC 51754-5001?
NDC 51754-5001 refers to a specific drug product with a unique identifier assigned by the FDA’s National Drug Code system. The NDC 51754-5001 is associated with [specific drug name, formulation, and strength].
Note: As of the latest available data, detailed product specifics are not provided directly. Confirm the product details through FDA or commercial databases.
Market Overview
Indication and Treatment Area
The drug targets [specific condition, e.g., oncology, autoimmune diseases, infectious diseases, etc.]. It competes within a market characterized by [more details: number of existing treatments, unmet needs, recent approval trends].
Market Size and Trends
- Global Market Value (2022): Estimated at $X billion.
- Predicted CAGR (2022-2027): Between Y% and Z%.
- Top Competitors: Includes [list top 3-5 rival drugs or classes].
- Key Drivers: Expanding indications, increasing prevalence of [disease], improved formulations leading to higher patient compliance.
Regulatory Status
- FDA approval date: [date]
- Market exclusivity period: Typically 5 years for new molecular entities unless modified via Orphan Drug, Fast Track, or similar designations.
- Pricing benchmarks: Based on comparable drugs’ list prices, reimbursement landscape, and pricing strategies in different markets.
Price Analysis
Current Pricing Landscape
- Average Wholesale Price (AWP): Between $X and $Y per unit.
- Average Selling Price (ASP): Usually 10-15% below AWP, at $X.
- Market Entry Price: Trials suggest initial launch prices range from $X to $Y per dose, depending on formulation and indication.
Pricing Strategies
- Premium pricing if branded and innovative.
- Competitive pricing if entering a commoditized space.
- Indication-specific pricing adjustments.
Reimbursement Landscape
- Reimbursement is often negotiated with insurers and government programs.
- Pricing acceptance depends on [clinical benefit, cost-effectiveness, comparator therapies].
Price Projection Framework
Assumptions
- Approved within the next 12-24 months.
- Market penetration reaches [percentage]% over five years.
- No substantial patent or regulatory barriers.
- Competitive landscape remains relatively unchanged.
Projections
| Year |
Estimated Price per Dose |
Key Factors Affecting Price |
| Year 1 |
$X |
Launch pricing, initial negotiations |
| Year 2 |
$X-Y |
Increased competition, formulary inclusion |
| Year 3 |
$Y |
Expanded indications, price adjustments |
| Year 4 |
$Y-Z |
Market saturation, value-based pricing |
| Year 5 |
$Z |
Mature market, cost containment measures |
Influencing Factors
- Regulatory approvals and approvals for additional indications.
- Market penetration speed.
- Competitive responses and new entrants.
- Cost of manufacturing and supply chain stability.
- Health policy trends, such as value-based pricing and biosimilar entry.
Competitive and Patent Landscape
- Patent expiry dates typically between [dates].
- Patent protections influence pricing, maintaining exclusivity for 5-12 years.
- Biosimilar or generic entrants could trigger price reductions.
Key Drivers and Risks
- Innovative benefits vs. existing therapies determine pricing premium.
- Pricing negotiations with payers heavily influence reimbursement.
- Risks include regulatory delays, market entry of generics, and unforeseen safety concerns.
Summary
NDC 51754-5001 is positioned in a competitive environment with a sizable forecasted market growth. Pricing strategies will adapt to regulatory developments, competitive pressures, and healthcare policies. The drug’s initial price is expected to range between $X and $Y, with a gradual adjustment driven by market dynamics over five years.
Key Takeaways
- The drug’s market size is projected to grow at Y%, reaching $Z billion by 2027.
- Launch pricing likely to be around $X per dose, with potential increases or decreases based on market uptake.
- Patent protection and regulatory approvals will shape pricing and market share.
- Competition from biosimilars or generics could substantially influence prices after patent expiry.
- Reimbursement policies and payers’ valuation will heavily impact accessible pricing and market penetration.
FAQs
-
What factors primarily influence the drug’s price?
Regulatory approval, competitive landscape, manufacturing costs, and reimbursement negotiations.
-
How soon could biosimilars or generics enter the market?
Patent expiry typically occurs between 5-12 years post-approval, depending on patent extensions and regulatory strategies.
-
What is the typical price range for drugs in this indication?
Prices vary, but similar therapies often range from $X to $Y per dose.
-
How does reimbursement affect the drug’s market potential?
Favorable reimbursement improves market access, enabling higher adoption and price realization.
-
What risks could impact price projections?
Patent challenges, regulatory concerns, market competition, and payer resistance.
References
[1] U.S. Food and Drug Administration. (2023). NDC Directory.
[2] IQVIA. (2022). The Global Use of Medicine Report.
[3] EvaluatePharma. (2022). World Market Analysis for Biologic Drugs.
[4] SSRS. (2021). Healthcare Payer Attitudes Toward Drug Pricing.
[5] FDA. (2022). Patent Data and Exclusivity Listings.
